Yan‐Wen Shu

517 total citations
11 papers, 254 citations indexed

About

Yan‐Wen Shu is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Yan‐Wen Shu has authored 11 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Yan‐Wen Shu's work include Atherosclerosis and Cardiovascular Diseases (4 papers), Immune Cell Function and Interaction (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). Yan‐Wen Shu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (4 papers), Immune Cell Function and Interaction (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). Yan‐Wen Shu collaborates with scholars based in China and United States. Yan‐Wen Shu's co-authors include Xiao-Fan Hu, Jun Yang, Dongxia Ma, Mengjun Wang, Min Yan, Yakun Li, Yuhua Liao, Longxian Cheng, Zhimin Wang and Kun Liu and has published in prestigious journals such as Journal of Biological Chemistry, Transplantation and Atherosclerosis.

In The Last Decade

Yan‐Wen Shu

11 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan‐Wen Shu China 7 95 79 39 37 35 11 254
Haïfa Sanhaji Tunisia 12 51 0.5× 69 0.9× 83 2.1× 39 1.1× 46 1.3× 36 319
Xinbo Zhang United States 6 71 0.7× 128 1.6× 57 1.5× 16 0.4× 59 1.7× 13 287
Jayakumar Manoharan Germany 7 52 0.5× 125 1.6× 40 1.0× 21 0.6× 44 1.3× 9 269
Parth Patel United States 10 48 0.5× 145 1.8× 61 1.6× 21 0.6× 33 0.9× 15 301
Bart Legein Germany 6 159 1.7× 103 1.3× 40 1.0× 25 0.7× 54 1.5× 8 337
Meng‐Yan Wang China 8 47 0.5× 102 1.3× 20 0.5× 24 0.6× 22 0.6× 15 238
Hongwei Yang China 10 44 0.5× 186 2.4× 34 0.9× 35 0.9× 75 2.1× 24 404
Cecilia Frej Sweden 6 52 0.5× 196 2.5× 39 1.0× 12 0.3× 68 1.9× 7 311
Wenxin Kou China 10 87 0.9× 157 2.0× 69 1.8× 29 0.8× 41 1.2× 21 355

Countries citing papers authored by Yan‐Wen Shu

Since Specialization
Citations

This map shows the geographic impact of Yan‐Wen Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Wen Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Wen Shu more than expected).

Fields of papers citing papers by Yan‐Wen Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Wen Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Wen Shu. The network helps show where Yan‐Wen Shu may publish in the future.

Co-authorship network of co-authors of Yan‐Wen Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Wen Shu. A scholar is included among the top collaborators of Yan‐Wen Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Wen Shu. Yan‐Wen Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mao, Yi, et al.. (2019). Relationship between Atrial Tissue Remodeling and ECG Features in Atrial Fibrillation. Current Medical Science. 39(4). 541–545. 2 indexed citations
2.
Li, Yakun, Dongxia Ma, Zhimin Wang, et al.. (2018). The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis. Pharmacological Research. 131. 102–111. 66 indexed citations
3.
Wang, Zhimin, Mengjun Wang, Xiao-Fan Hu, et al.. (2018). Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model. Transplantation. 103(3). 502–511. 19 indexed citations
4.
Chen, Weijun, Xiao-Fan Hu, Min Yan, et al.. (2015). Human umbilical vein endothelial cells promote the inhibitory activation of CD4+CD25+Foxp3+ regulatory T cells via PD-L1. Atherosclerosis. 244. 108–112. 28 indexed citations
5.
Li, Sihui, Weijun Chen, Min Yan, Yan‐Wen Shu, & Yuhua Liao. (2015). Expression of coinhibitory PD-L1 on CD4+CD25+FOXP3+ regulatory T cells is elevated in patients with acute coronary syndrome. Coronary Artery Disease. 26(7). 598–603. 24 indexed citations
6.
Dai, Miao, Yimei Du, Yufeng Yao, et al.. (2015). [Combined transgenic inhibition of CaMKII and Ik1 on cardiac remodeling].. PubMed. 67(2). 201–6. 1 indexed citations
7.
Wu, Hongjun, et al.. (2014). [Comparison of plasma inflammatory factors in patients with acute aortic dissection among different grouping].. PubMed. 26(10). 740–2. 2 indexed citations
8.
Jia, Peng, Jue Wang, Li Wang, et al.. (2013). TNF‐α Upregulates Fgl2 Expression in Rat Myocardial Ischemia/Reperfusion Injury. Microcirculation. 20(6). 524–533. 25 indexed citations
9.
Wang, Jun, Yan‐Wen Shu, Tingting Tang, et al.. (2013). Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome.. Journal of Biological Chemistry. 288(52). 37365–37365. 3 indexed citations
10.
Wang, Jun, Yan‐Wen Shu, Tingting Tang, et al.. (2012). Impaired Thymic Export and Increased Apoptosis Account for Regulatory T Cell Defects in Patients with Non-ST Segment Elevation Acute Coronary Syndrome. Journal of Biological Chemistry. 287(41). 34157–34166. 45 indexed citations
11.
Yang, Yong, et al.. (2012). Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities. Phytotherapy Research. 27(9). 1321–1327. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026